List view / Grid view
In this interview, Adrian van den Hoven, Director General of…
In this interview, Adrian van den Hoven, Director General of Medicines for Europe, discusses all things supply of generic and biosimilar medicines for the continent. Also, in a bonus video, Adrian discusses challenges disrupting access to biosimilars and generics in Europe.
Junior Editors of European Pharmaceutical Review, Hannah Balfour and Victoria…
Junior Editors of European Pharmaceutical Review, Hannah Balfour and Victoria Rees, discuss some of the most noteworthy news and announcements from this year.
Drug shortages can greatly impact patients and the pharmaceutical industry.…
Drug shortages can greatly impact patients and the pharmaceutical industry. Adrian van den Hoven, Director General of Medicines for Europe, explains how to prevent and reduce the effects of medicinal scarcities in the EU.
The EC has released a report that has found generics…
The EC has released a report that has found generics and biosimilars decrease wasteful spending and maintain health quality in the EU.
The associations representing the European and British life science industry…
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...
